Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Urban Arnelo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1843-5673; OpenAlex author ID A5000830051. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 0, last author 2)
Trials
2
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2006: 2 trials · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: none · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 10

  1. Endoscopic workup in pancreatic cancer. Last author DOI 10.1097/js9.0000000000000777↗
  2. Author Correction: Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cance… Co-author DOI 10.1038/s41598-022-08527-z↗
  3. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.07.009↗
  4. Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection. Co-author DOI 10.1021/acs.jproteome.1c00018↗
  5. Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties. Co-author DOI 10.1080/19490976.2021.1983101↗
  6. Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience. Co-author DOI 10.1097/sla.0000000000003301↗
  7. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer. Co-author DOI 10.1016/j.hpb.2018.07.017↗
  8. Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer. Co-author DOI 10.1038/s41598-019-46634-6↗
  9. Palliative therapy in pancreatic cancer-interventional treatment with stents. Co-author DOI 10.21037/tgh.2019.01.05↗
  10. Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer. Last author DOI 10.1001/jamasurg.2017.2228↗

Trials 2

  1. Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail Study director NCT00500968↗
  2. Preoperative Stent Study Study director NCT00501176↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Roberto Valente · 9 shared papers, 2017–2024 · strength 1.24
  2. Marco Del Chiaro · 6 shared papers, 2017–2021 · strength 0.72
  3. Margaret Chen · 4 shared papers, 2019–2022 · strength 0.46
  4. Rogier Aäron Gaiser · 4 shared papers, 2019–2022 · strength 0.46
  5. Carlos Fernández Moro · 3 shared papers, 2019–2022 · strength 0.34
  6. Asif Halimi · 3 shared papers, 2019–2021 · strength 0.33
  7. Alessandro Coppola · 1 shared paper, 2024 · strength 0.31
  8. Matthias J. Löhr · 2 shared papers, 2019–2021 · strength 0.27
  9. Marco Del Chiaro · 2 shared papers, 2019–2022 · strength 0.23
  10. Elena B. Rangelova · 2 shared papers, 2019–2021 · strength 0.23
  11. Marcus Holmberg · 1 shared paper, 2021 · strength 0.15
  12. Ernesto Sparrelid · 1 shared paper, 2021 · strength 0.15
  13. Poya Ghorbani · 1 shared paper, 2021 · strength 0.15
  14. Stefan Gilg · 1 shared paper, 2021 · strength 0.15
  15. Alexander Waldthaler · 1 shared paper, 2019 · strength 0.12
  16. Ann Morgell · 1 shared paper, 2021 · strength 0.12
  17. Angelo D’Alessandro · 1 shared paper, 2021 · strength 0.12
  18. Caroline Sophie Verbeke · 1 shared paper, 2019 · strength 0.10
  19. Lars R. Lundell · 2 shared trials, 2006 · strength 0.06
  20. Lars Enochsson · 1 shared trial, 2006 · strength 0.03
  21. Farshad Frozanpor · 1 shared trial, 2006 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.